Veradermics, Inc. (MANE)

103.96 -1.36 (-1.29%) USD  |  NYSE  |  May 21, 11:31
More

Veradermics EV to Revenues

EV to Revenues Chart

View EV to Revenues for MANE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EV to Revenues Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EV to Revenues Range, Past 5 Years

View EV to Revenues Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to Revenues Benchmarks

View EV to Revenues Benchmarks
Start Trial
Organon & Co. Upgrade
Merck & Co., Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
Terns Pharmaceuticals, Inc. (DELISTED) --
Corcept Therapeutics, Inc. Upgrade

EV to Revenues Related Metrics

EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade